Qube Research & Technologies (QRT)
AVNS

Qube Research & Technologies (QRT)’s Avanos Medical AVNS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
554,350
+424,757
+328% +$9.94M 0.01% 1100
2026
Q1 		$1.82M Sell
129,593
-573,322
-82% -$7.72M ﹤0.01% 2232
2025
Q4 		$7.89M Sell
702,915
-24,923
-3% -$285K 0.01% 1496
2025
Q3 		$8.41M Buy
727,838
+102,429
+16% +$1.2M 0.01% 1431
2025
Q2 		$7.66M Buy
625,409
+153,547
+33% +$1.93M 0.01% 1461
2025
Q1 		$6.76M Buy
471,862
+360,071
+322% +$5.62M 0.01% 1375
2024
Q4 		$1.78M Buy
+111,791
New +$2.21M ﹤0.01% 1928
2024
Q3 		– Sell
-38,002
Closed -$757K – 3306
2024
Q2 		$757K Sell
38,002
-65,418
-63% -$1.27M ﹤0.01% 2000
2024
Q1 		$2.06M Sell
103,420
-16
-0% -$309 ﹤0.01% 1736
2023
Q4 		$2.32M Buy
103,436
+30,203
+41% +$623K ﹤0.01% 1452
2023
Q3 		$1.48M Buy
73,233
+57,040
+352% +$1.29M ﹤0.01% 1543
2023
Q2 		$414K Buy
+16,193
New +$426K ﹤0.01% 1566
2022
Q4 		– Sell
-18,032
Closed -$393K – 2459
2022
Q3 		$393K Sell
18,032
-1,168
-6% -$30.5K ﹤0.01% 1548
2022
Q2 		$525K Sell
19,200
-9,408
-33% -$270K ﹤0.01% 1388
2022
Q1 		$958K Buy
+28,608
New +$921K 0.01% 1196
2021
Q4 		– Sell
-8,899
Closed -$278K – 2519
2021
Q3 		$278K Sell
8,899
-7,126
-44% -$242K ﹤0.01% 1517
2021
Q2 		$583K Buy
16,025
+6,898
+76% +$285K 0.01% 1203
2021
Q1 		$399K Buy
9,127
+4,586
+101% +$215K 0.01% 1309
2020
Q4 		$208K Buy
+4,541
New +$189K ﹤0.01% 1518
2018
Q4 		– Sell
-1,749
Closed -$120K – 336
2018
Q3 		$120K Buy
1,749
+1,575
+905% +$101K 0.02% 697
2018
Q2 		$10K Buy
+174
New +$9.19K 0.01% 758

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AVNS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Avanos Medical (AVNS) stake by 328% in Q2 2026, buying an estimated $9.94M and bringing the position to 554,350 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #1100.

Qube Research & Technologies (QRT) first reported a position in AVNS in Q2 2018 and has held it in 21 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Qube Research & Technologies (QRT) held 554,350 shares of Avanos Medical worth $13.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 424,757 Avanos Medical shares in Q2 2026, an estimated $9.94M.
  • Avanos Medical made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1100 holding.
  • Qube Research & Technologies (QRT) first reported a position in Avanos Medical in Q2 2018 and has held it in 21 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.